Wikidata entity: Q425120
C₂₁H₂₉N₃O (P274)
Quantities
| P2067 | mass | 339.231 |
| P3780 | active ingredient in | ... | Q47521911 (Norpace) | Norpace |
| P233 | canonical SMILES | String | CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C | ??? |
| P373 | Commons category | String | Disopyramide | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P8026 | LiverTox likelihood score | ... | Q83284157 (LiverTox toxicity likelihood category B) | LiverTox toxicity likelihood category B |
| P2175 | medical condition treated | ... | Q815819 (atrial fibrillation) | atrial fibrillation |
| P129 | physically interacts with | ... | Q905000 (Potassium voltage-gated channel subfamily H member 2) | Potassium voltage-gated channel subfamily H member 2 |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P3489 | pregnancy category | ... | Q3679233 (Australian pregnancy category B2) | Australian pregnancy category B2 |
| P769 | significant drug interaction | ... | Q41576 (cocaine) | cocaine |
| P769 | significant drug interaction | ... | Q7739 (arsenic trioxide) | arsenic trioxide |
| P769 | significant drug interaction | ... | Q58375 (thioridazine) | thioridazine |
| P769 | significant drug interaction | ... | Q58396 (imipramine) | imipramine |
| P769 | significant drug interaction | ... | Q58397 (amitriptyline) | amitriptyline |
| P769 | significant drug interaction | ... | Q174259 (droperidol) | droperidol |
| P769 | significant drug interaction | ... | Q179996 ((RS)-methadone) | (RS)-methadone |
| P769 | significant drug interaction | ... | Q144085 (pimozide) | pimozide |
| P769 | significant drug interaction | ... | Q165399 (azithromycin) | azithromycin |
| P769 | significant drug interaction | ... | Q407883 (ketoconazole) | ketoconazole |
| P769 | significant drug interaction | ... | Q407972 (chlorpromazine) | chlorpromazine |
| P769 | significant drug interaction | ... | Q58713 (clomipramine) | clomipramine |
| P769 | significant drug interaction | ... | Q118551 (clarithromycin) | clarithromycin |
| P769 | significant drug interaction | ... | Q228143 (zuclopenthixol) | zuclopenthixol |
| P769 | significant drug interaction | ... | Q251347 (haloperidol) | haloperidol |
| P769 | significant drug interaction | ... | Q408163 (anagrelide) | anagrelide |
| P769 | significant drug interaction | ... | Q408637 (dronedarone) | dronedarone |
| P769 | significant drug interaction | ... | Q409672 ((RS)-citalopram) | (RS)-citalopram |
| P769 | significant drug interaction | ... | Q417597 (procainamide) | procainamide |
| P769 | significant drug interaction | ... | Q417909 (terfenadine) | terfenadine |
| P769 | significant drug interaction | ... | Q418130 (nebivolol) | nebivolol |
| P769 | significant drug interaction | ... | Q419394 (sevoflurane) | sevoflurane |
| P769 | significant drug interaction | ... | Q410291 (verapamil) | verapamil |
| P769 | significant drug interaction | ... | Q411229 (itraconazole) | itraconazole |
| P769 | significant drug interaction | ... | Q410011 (ondansetron) | ondansetron |
| P769 | significant drug interaction | ... | Q410061 (amiodarone) | amiodarone |
| P769 | significant drug interaction | ... | Q421381 (flecainide) | flecainide |
| P769 | significant drug interaction | ... | Q421937 ((RS)-hydroxyzine) | (RS)-hydroxyzine |
| P769 | significant drug interaction | ... | Q422418 ((RS)-sulpiride) | (RS)-sulpiride |
| P769 | significant drug interaction | ... | Q662511 ((RS)-propafenone) | (RS)-propafenone |
| P769 | significant drug interaction | ... | Q736270 (mefloquine) | mefloquine |
| P769 | significant drug interaction | ... | Q794162 (betaxolol) | betaxolol |
| P769 | significant drug interaction | ... | Q411325 (atenolol) | atenolol |
| P769 | significant drug interaction | ... | Q412236 (voriconazole) | voriconazole |
| P769 | significant drug interaction | ... | Q412496 (quinidine) | quinidine |
| P769 | significant drug interaction | ... | Q422438 (chloroquine) | chloroquine |
| P769 | significant drug interaction | ... | Q422618 (ritonavir) | ritonavir |
| P769 | significant drug interaction | ... | Q3993743 ((Z)-Toremifene) | (Z)-Toremifene |
| P769 | significant drug interaction | ... | Q4890934 (bepridil) | bepridil |
| P769 | significant drug interaction | ... | Q5186964 (crizotinib) | crizotinib |
| P769 | significant drug interaction | ... | Q6821618 (mesoridazine) | mesoridazine |
| P769 | significant drug interaction | ... | Q7914515 (vandetanib) | vandetanib |
| P769 | significant drug interaction | ... | Q422645 (efavirenz) | efavirenz |
| P769 | significant drug interaction | ... | Q422970 ((±)-promethazine) | (±)-promethazine |
| P769 | significant drug interaction | ... | Q906453 (posaconazole) | posaconazole |
| P769 | significant drug interaction | ... | Q413591 (sotalol) | sotalol |
| P769 | significant drug interaction | ... | Q416206 (pentamidine) | pentamidine |
| P769 | significant drug interaction | ... | Q213511 (erythromycin) | erythromycin |
| P769 | significant drug interaction | ... | Q221361 (clozapine) | clozapine |
| P769 | significant drug interaction | ... | Q10354103 (probucol) | probucol |
| P769 | significant drug interaction | ... | Q71704041 ((E/Z)-doxepin) | (E/Z)-doxepin |
| P769 | significant drug interaction | ... | Q423364 (propranolol) | propranolol |
| P769 | significant drug interaction | ... | Q423437 (astemizole) | astemizole |
| P769 | significant drug interaction | ... | Q423498 (trimipramine) | trimipramine |
| P769 | significant drug interaction | ... | Q423757 (escitalopram) | escitalopram |
| P769 | significant drug interaction | ... | Q424238 (domperidone) | domperidone |
| P769 | significant drug interaction | ... | Q424940 (moxifloxacin) | moxifloxacin |
| P769 | significant drug interaction | ... | Q947595 (halofantrine) | halofantrine |
| P769 | significant drug interaction | ... | Q976559 (sparfloxacin) | sparfloxacin |
| P769 | significant drug interaction | ... | Q3712521 (dofetilide) | dofetilide |
| P769 | significant drug interaction | ... | Q3791612 (ibutilide) | ibutilide |
| P769 | significant drug interaction | ... | Q3896970 (pasireotide) | pasireotide |
| P769 | significant drug interaction | ... | Q425137 (fingolimod) | fingolimod |
| P769 | significant drug interaction | ... | Q425295 (cisapride) | cisapride |
| P769 | significant drug interaction | ... | Q425729 (ivabradine) | ivabradine |
| P279 | subclass of | ... | Q47317020 (pyridine) | pyridine |
| P279 | subclass of | ... | Q72801119 (tertiary amine) | tertiary amine |
| P279 | subclass of | ... | Q73261544 (primary carboxamide) | primary carboxamide |
| P279 | subclass of | ... | Q121144720 (phenyl compound) | phenyl compound |
| P2868 | subject has role | ... | Q241549 (antiarrhythmic agent) | antiarrhythmic agent |
| P2868 | subject has role | ... | Q50430448 (voltage-gated sodium channel blockers) | voltage-gated sodium channel blockers |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | disopyramide | ??? |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | disopyramidum | ??? |
| P267 | ATC code | C01BA03 |
| P231 | CAS Registry Number | 3737-09-5 |
| P683 | ChEBI ID | 4657 |
| P592 | ChEMBL ID | CHEMBL517 |
| P661 | ChemSpider ID | 3002 |
| P9272 | DeCS ID | 4267 |
| P715 | DrugBank ID | DB00280 |
| P11198 | DrugCentral ID | 926 |
| P8494 | DSSTOX compound identifier | DTXCID9025536 |
| P3117 | DSSTox substance ID | DTXSID1045536 |
| P232 | EC number | 223-110-2 |
| P2566 | ECHA Substance Infocard ID | 100.021.010 |
| P646 | Freebase ID | /m/0bx7lw |
| P595 | Guide to Pharmacology Ligand ID | 7167 |
| P2057 | Human Metabolome Database ID | HMDB0014425 |
| P234 | InChI | InChI=1S/C21H29N3O/c1-16(2)24(17(3)4)15-13-21(20(22)25,18-10-6-5-7-11-18)19-12-8-9-14-23-19/h5-12,14,16-17H,13,15H2,1-4H3,(H2,22,25) |
| P235 | InChIKey | UVTNFZQICZKOEM-UHFFFAOYSA-N |
| P665 | KEGG ID | D00303 |
| P665 | KEGG ID | C06965 |
| P7830 | LiverTox ID | Disopyramide |
| P6689 | MassBank accession ID | MSBNK-Waters-WA000838 |
| P6689 | MassBank accession ID | MSBNK-Waters-WA000839 |
| P6689 | MassBank accession ID | MSBNK-Waters-WA000840 |
| P6689 | MassBank accession ID | MSBNK-Waters-WA000841 |
| P6689 | MassBank accession ID | MSBNK-Waters-WA000842 |
| P10245 | MedlinePlus drug identifier | a682408 |
| P486 | MeSH descriptor ID | D004206 |
| P672 | MeSH tree code | D03.383.725.227 |
| P6366 | Microsoft Academic ID (discontinued) | 2779831137 |
| P2115 | NDF-RT ID | N0000147821 |
| P10283 | OpenAlex ID | C2779831137 |
| P11199 | Probes And Drugs ID | PD002749 |
| P662 | PubChem CID | 3114 |
| P1579 | Reaxys registry number | 492056 |
| P3345 | RxNorm CUI | 3541 |
| P5076 | Römpp online ID | RD-04-02044 |
| P2877 | SureChEMBL ID | 16153 |
| P2892 | UMLS CUI | C0012702 |
| P11089 | UniChem compound ID | 611798 |
| P652 | UNII | GFO928U8MQ |
| P11143 | WikiProjectMed ID | Disopyramide |
| P3350 | World Health Organisation international non-proprietary name numeric ID | 1307 |
Why not click here or view trends?
log id: 1637462